Bridgeway Capital Management’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $33.1K | Hold |
|
|||||
|
2023
Q3 | $26.2K | Sell |
|
|||||
|
2023
Q2 | $693K | Hold |
|
|||||
|
2023
Q1 | $431K | Sell |
|
|||||
|
2022
Q4 | $485K | Buy |
|
|||||
|
2022
Q3 | $459K | Buy |
|
|||||
|
2022
Q2 | $220K | Hold |
|
|||||
|
2022
Q1 | $365K | Sell |
|
|||||
|
2021
Q4 | $710K | Sell |
|
|||||
|
2021
Q3 | $986K | Buy |
|
|||||
|
2021
Q2 | $928K | Sell |
|
|||||
|
2021
Q1 | $1.16M | Buy |
|
|||||
|
2020
Q4 | $733K | Sell |
|
|||||
|
2020
Q3 | $1.29M | Hold |
|
|||||
|
2020
Q2 | $580K | Buy |
|
|||||
|
2020
Q1 | $230K | Buy |
|